Toggle navigation
About Us
Business Areas
R & D
Manufacturing
Beyond Business
Investors
Careers
Contact Us
Investors
Investors > FY 2011-12
Overview
Chairman's Statement
Shareholder Information
Policies or Statutory Documents
IEPF
Debentures
Amalgamation
MOA/AOA
Procedure for Dematerialisation of Shares
Archives
Credit Ratings
CSR
AGM Transcript
Annual Return
Disclosures under Regulation 46 and 62 of SEBI LODR
Financial
2022-23
2021-22
2020-21
2019-20
2018-19
2017-18
2016-17
2015-16
2014-15
2013-14
2012-13
2011-12
Investors > FY 2011-12
1. Annual Report
Annual Report
2. Intimation to Stock Exchange
Quarterly Compliance Report Q2
Quarterly Compliance Report Q1
3. Quarterly Results
Q1 11-12
Q2 11-12
Q3 11-12
Q4 11-12
Investors Conference Call Transcripts
Stand Alone Results
Consolidated Results
Investors Conference Call Transcripts
Stand Alone Results
Consolidated Results
Press Release 21% revenue growth in Q3 FY12
Investors Conference Call Transcripts
Stand Alone Results
Consolidated Results
Press Release on Q4 Results
Investors Conference Call Transcripts
Stand Alone Results
Consolidated Results
Details of Nodal Officer
Name
: Chintan Trivedi
Designation
: Company Secretary
E-mail Id
: investorservices@torrentpharma.com
IEPF Authority - Refund web page
IEPF Authority - Refund web page >>
